Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination
Article in Annals of Clinical and Translational Neurology (May 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Annals of Clinical and Translational Neurology (May 2024)
Article in The Journal of Infectious Diseases (April 2024)
Article in Viruses (April 2024)